Steward Partners Investment Advisory, LLC Mirum Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,800 shares of MIRM stock, worth $120,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,800
Previous 8,664
67.68%
Holding current value
$120,428
Previous $337,000
65.88%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$283 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$197 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$139 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$120 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$112 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.58B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...